Filing Details

Accession Number:
0000899243-22-003917
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-01 19:18:02
Reporting Period:
2021-12-22
Accepted Time:
2022-02-01 19:18:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641281 Bolt Biotherapeutics Inc. BOLT Pharmaceutical Preparations (2834) 472804636
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1821419 A. Edith Perez C/O Bolt Biotherapeutics, Inc.
900 Chesapeake Drive
Redwood City CA 94063
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-04 917 $16.65 917 No 4 P Direct
Common Stock Acquisiton 2021-12-06 411 $4.64 1,328 No 4 P Direct
Common Stock Acquisiton 2021-12-22 35,714 $2.80 37,042 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-12-22 35,714 $0.00 35,714 $2.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
189,286 2030-07-28 No 4 M Direct
Footnotes
  1. These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
  2. 1/4th of the shares subject to the option shall vest on the one year anniversary of April 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a service provider through each such date.